Lutz J - Search Results

1

Continuous venovenous hemodialysis treatment in critically ill patients after liver transplantation.

Lütkes P, Lutz J, Loock J, Daul A, Broelsch C, Philipp T, Heemann U. Lütkes P, et al. Among authors: lutz j. Kidney Int Suppl. 1999 Nov;(72):S71-4. Kidney Int Suppl. 1999. PMID: 10560810 Free article.

2

Tumours after kidney transplantation.

Lutz J, Heemann U. Lutz J, et al. Curr Opin Urol. 2003 Mar;13(2):105-9. doi: 10.1097/00042307-200303000-00004. Curr Opin Urol. 2003. PMID: 12584469 Review.

3

Prolonged catheter survival in intermittent hemodialysis using a less thrombogenic micropatterned polymer modification.

Baumann M, Witzke O, Dietrich R, Haug U, Deppisch R, Lutz J, Philipp T, Heemann U. Baumann M, et al. Among authors: lutz j. ASAIO J. 2003 Nov-Dec;49(6):708-12. doi: 10.1097/01.mat.0000093969.27009.ab. ASAIO J. 2003. PMID: 14655739 Clinical Trial.

4

OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection.

Patschan D, Kribben A, Pietruck F, Lutz J, Binek M, Philipp T, Heemann U, Witzke O. Patschan D, et al. Among authors: lutz j. Nephron Clin Pract. 2006;103(3):c94-9. doi: 10.1159/000092017. Epub 2006 Mar 13. Nephron Clin Pract. 2006. PMID: 16534238 Clinical Trial.

5

Pathophysiology and treatment options of chronic renal allograft damage.

Heemann U, Lutz J. Heemann U, et al. Among authors: lutz j. Nephrol Dial Transplant. 2013 Oct;28(10):2438-46. doi: 10.1093/ndt/gft087. Epub 2013 Apr 25. Nephrol Dial Transplant. 2013. PMID: 23625970 Review.

6

Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.

Szabo A, Lutz J, Schleimer K, Antus B, Hamar P, Philipp T, Heemann U. Szabo A, et al. Among authors: lutz j. Kidney Int. 2000 Mar;57(3):982-91. doi: 10.1046/j.1523-1755.2000.00926.x. Kidney Int. 2000. PMID: 10720951 Free article.

7

Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone.

Antus B, Yao Y, Liu S, Song E, Lutz J, Heemann U. Antus B, et al. Among authors: lutz j. Kidney Int. 2001 Nov;60(5):1955-63. doi: 10.1046/j.1523-1755.2001.00007.x. Kidney Int. 2001. PMID: 11703615 Free article.

8

Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration.

Wang M, Liu S, Ouyang N, Song E, Lutz J, Heemann U. Wang M, et al. Among authors: lutz j. Kidney Int. 2004 Sep;66(3):1248-56. doi: 10.1111/j.1523-1755.2004.00878.x. Kidney Int. 2004. PMID: 15327424 Free article.

9

Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury : possible connection to an interleukin-6-dependent pathway.

Heemann U, Szabo A, Hamar P, Müller V, Witzke O, Lutz J, Philipp T. Heemann U, et al. Among authors: lutz j. Am J Pathol. 2000 Jan;156(1):287-93. doi: 10.1016/S0002-9440(10)64729-3. Am J Pathol. 2000. PMID: 10623677 Free PMC article.

10

FLIM58, a blocking peptide for FAS ligand, reduces apoptotic cell death of allogenic-transplanted hepatocytes in spleen.

Song E, Chen J, Lutz J, Wang M, Heemann U. Song E, et al. Among authors: lutz j. Transplant Proc. 2001 Feb-Mar;33(1-2):650. doi: 10.1016/s0041-1345(00)02184-9. Transplant Proc. 2001. PMID: 11266999 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,021 results

Search Page

Filters